Cariprazine and Cognition in Patients with Schizophrenia and Bipolar Disorder: A Systematic Review

Thumbnail Image

Files

Cariprazine and cognition in patients_2024.pdf (859.5 KB)
Identifiers
URI: http://hdl.handle.net/11268/13335
DOI: 10.1097/HRP.0000000000000411

Publication date

2024

Authors

Advisors

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

SDG

goal-3

Metrics

Google Scholar

Research Projects

Organizational Units

Journal Issue

Abstract

Cariprazine (CAR), an antipsychotic with partial agonism at the D3 receptor and higher affinity than dopamine, has shown significant procognitive effects in preclinical animal studies. This study systematically reviews CAR's effects on cognitive measures in patients with schizophrenia and bipolar disorder.

Description

UNESCO Subjects

Psiquiatría
Psicosis
Publicación científica

Keywords

Bibliographic reference

García-Fernández, L., Romero-Ferreiro, V., Peñuelas-Calvo, I., Álvarez-Mon, M. A., Scala, M., Romero-Ferreiro, C., López, E. J., Santos, J. L., & Rodriguez-Jimenez, R. (2024). Cariprazine and cognition in patients with schizophrenia and bipolar disorder: A systematic review. Harvard Review of Psychiatry, 32(6), 207-217. https://doi.org/10.1097/HRP.0000000000000411
Editor's version
http://doi.org/10.1097/HRP.0000000000000411

Type of document

journal article

Collections

Otras Áreas de Investigación de Salud
Attribution 4.0 International

La licencia de este ítem se describe como Attribution 4.0 International